Volta para página inicial do evento

Program

Scientific Program · November 3–5, 2026

CEL-GEN 2026

Congress of the Brazilian Association of Cell and Gene Therapy

Prodigy Santos Dumont · Rio de Janeiro, Brazil

DAY 01

Tuesday, November 3, 2026

08:30 – 20:40
08:30 – 09:15

Industry workshops

45 min presentation

Room 1

MERCK

Overcoming cost and timeline challenges in AAV and lentivirus manufacturing

David Bohonak (United States)

09:15 – 09:45

Coffee break

09:45 – 10:15

Opening Session

Room 1

10:15 – 11:00
Room 1

President's Session

Chair: Martin Bonamino

INCA / Fiocruz · Brazil

James M. Wilson10:15 – 11:00

Gemma Therapeutics · United States

Genetic Medicine Platforms for Rare Disease

11:00 – 12:00
Room 1

Tumor Infiltrating Lymphocytes

Chair: Lucia Silla

HCPA-UFRGS · Brazil

Tiago Medina11:00 – 11:22

University of Southern Denmark · Denmark

Overcoming TIL limitations via epigenetic therapy

Luciana Cavalheiro Marti11:23 – 11:45

Einstein Hospital Israelita · Brazil

Establishing an Advanced Cell Therapy Platform for TIL-Based Immunotherapy

12:00 – 13:30

Industry workshops

45 min presentation

Room 2

VectorBuilder

VectorBuilder: A Partner for Drug Development

Andrew Alcock (United Kingdom)

13:30 – 14:45
Room 1

RNA Therapies

Competence Center for mRNA Vaccines and Therapies

Chair: Pedro Guimaraes

UFMG · Brazil

Santuza Maria Ribeiro Teixeira13:30 – 13:50

UFMG · Brazil

mRNA vaccines for Chagas disease

Jamile Ramos da Silva13:50 – 14:10

Einstein Hospital Israelita · Brazil

Expanding the reach of mRNA-LNP therapeutics: Cancer vaccines and beyond

Dinler Amaral Antunes14:10 – 14:30

United States

Artificial Intelligence in the Design of Personalized Therapies and Vaccines

Room 2

Advances in Gene Therapy, Cell Therapy and Multiomics

IMASP

Chair: Roberto Giugliani

HCPA · Brazil

James M. Wilson13:30 – 13:50

Gemma Therapeutics · United States

Gene Therapy in Developing Countries: Challenges and Prospects

Milena Botelho Pereira Soares13:50 – 14:10

Fiocruz-BA · Brazil

Immunomodulation by genetically engineered mesenchymal stromal cells

Iscia Lopes-Cendes14:10 – 14:30

UNICAMP · Brazil

The Molecular Architecture of Epilepsy: Integrating Genomics, Multi-omics and Single-Cell Technologies

14:45 – 16:00
Room 1

Viral Delivery

Chair: Vinicius de Toledo Ribas

UFMG · Brazil

Veronica Lopez14:45 – 15:05

Instituto Leloir · Argentina

Adenovirus-Based Gene Therapy for Cancer: From Targeted Delivery to Antitumor Immunity

Marcio Chaim Bajgelman15:05 – 15:25

CNPEM · Brazil

Engineering Next-Generation Cancer Immunotherapies: From Gene Delivery to Immunomodulatory Nanoplatforms

Maria Carolina Silva15:25 – 15:32

Oral presentation · Abstract 80 · Brazil

Neurogenin 2 overexpression in corticospinal neurons modulates early neuronal and microglial responses after spinal cord injury

Rafael de Freitas Azevedo Repossi15:32 – 15:39

Oral presentation · Abstract 153 · Brazil

AAV-mediated overexpression of cannabinoid CB1 receptors preserves functional responses in a mouse model of retinitis pigmentosa: Perspectives for a nationally developed gene therapy in a rare disease

Room 2

iPSCs and Disease Modelling

Chair: Stevens Rehen

Instituto D'Or · Brazil

Bárbara da Costa Monte-Mór14:45 – 15:05

INCA-RJ · Brazil

Modeling Leukemic Transformation In Vitro Using iPSCs

Patricia Braga15:05 – 15:25

USP · Brazil

Decoding Neuroviral Impact on Brain Development Using Human iPSC-Derived Organoids

Artur Christian Garcia Da Silva15:25 – 15:32

Oral presentation · Abstract 37 · Brazil

Bioengineering a human lung-on-a-chip platform toward immune-informed preclinical modeling of pulmonary advanced therapies

Melaine Maiara Da Silva Lopes15:32 – 15:39

Oral presentation · Abstract 66 · Brazil

Development and Validation of a CAPN1 Knockout SH-SY5Y Cell Model via CRISPR-Cas9 for SPG76 Studies

16:00 – 16:30

Coffee break

16:30 – 17:45
Room 1

CAR-T for Onco and Immune Diseases

INCT-TOP

Chair: Virginia Picanço-Castro

Hemocentro Ribeirão Preto · Brazil

Diego Villa Clé16:30 – 16:50

FMRP-USP · Brazil

Academic CAR-T in Clinical Practice: Implementation, Challenges, and Real-World Outcomes in Ribeirão Preto

Marina Carolina de Oliveira Rodrigues16:50 – 17:10

FMRP-USP · Brazil

CAR-T Beyond Cancer: Immune Reset Strategies for Autoimmune Diseases

Lorena Lôbo de Figueiredo Pontes17:10 – 17:30

FMRP-USP · Brazil

CD33-Targeted Immunotherapies in AML: Engineering CAR-T and CAR-NK Strategies

Room 2

Bioengineering and Tissue Engineering

Chair: Monize Caiado Decarli

Netherlands

Marlon Lemos Dias16:30 – 16:50

UFRJ · Brazil

Bioengineering of diseased livers: lessons for liver transplantation

Silvya Stuchi Maria-Engler16:50 – 17:10

FCF-USP · Brazil

Engineering Human Skin Models: From Preclinical Disease Modelling to Personalised Melanoma Immunotherapy

Matheus Villanueva Andrade17:10 – 17:17

Oral presentation · Abstract 19 · Brazil

Experimental evolution of Zika virus for adaptation in differentiated cells of glioblastoma to enhance oncolytic activity

Larissa Emlym Alves Pinto17:17 – 17:24

Oral presentation · Abstract 24 · Brazil

Air-Jet-Generated Alginate Microgels Enable Controlled and Functional Release of AAV Vectors for Gene Therapy Applications

17:45 – 18:10

Networking

18:10 – 19:10
Room 1

Gene Therapy - Translation and Clinical Trials

Chair: Martin Bonamino

INCA / Fiocruz · Brazil

Jonathan Yen18:10 – 18:32

St. Jude Children's Research Hospital · United States

Base editor RNPs for fetal hemoglobin induction: preclinical development of SAGES2 for sickle cell disease

Leszek Lisowski18:33 – 18:55

CMRI / Gene2Cure · Australia

AAV-based Gene Therapy Revolution: How did we get here and what is next?

19:10 – 20:40

Poster Session I

DAY 02

Wednesday, November 4, 2026

08:30 – 20:15
08:30 – 09:15

Industry workshops

45 min presentation

ABTCel-Gen (ABTA) General Assembly

Room 1

Beckman

Characterizing EV-Based Therapeutics: Analytical Strategies and the Role of Nanoflow Cytometry

Bruno Solano de Freitas Souza (Brazil)

Room 2

Maxcyte

The MaxCyte Genome Engineering Journey: From Guide Selection to Clinical Cell Therapy Manufacturing

Nitin Kulkarni (United States)

09:15 – 10:30
Room 1

Novel Tools in Gene Editing

Chair: Thyago Leal Calvo

Instituto D'Or · Brazil

Ângela Saito09:15 – 09:35

CNPEM · Brazil

From Disease Models to Precision Gene Therapy: CRISPR and Prime Editing in Mucopolysaccharidosis Type I (Hurler Syndrome)

Davi Coe Torres09:35 – 09:55

Einstein Hospital Israelita · Brazil

Toward Safer Base Editors: Rewiring the Deaminase-Cas Architecture

Danielle Gonçalves de Carvalho09:55 – 10:02

Oral presentation · Abstract 107 · Brazil

Sustained reactivation of fetal hemoglobin by adenine base editors in human hematopoietic stem cells for sickle cell disease

Jefferson Pedroso10:02 – 10:09

Oral presentation · Abstract 28 · Brazil

Gene Therapy with Adeno-Associated Viral Vector Serotype 9 in Cellular Models for Glutaric Acidemia Type I Developed via CRISPR/Cas9 Gene Editing

Room 2

GMP Manufacturing

Chair: Amanda Mizukami Martins

Hemocentro Ribeirão Preto · Brazil

Lucia Silla09:15 – 09:35

HCPA-UFRGS · Brazil

NK cell adoptive Immunotherapy for Acute Myeloid Leukemia

Mariana Morato Marques09:35 – 09:55

Einstein Hospital Israelita · Brazil

From Research to GMP: The role of a Cleanroom Facility in Advanced Therapy Development

Carlos Melo09:55 – 10:02

Oral presentation · Abstract 88 · Brazil

Lentiviral Vector Platform based on Packaging Cell Line Engineering and GMP-Oriented Process Development

Daniela Tupy de Godoy10:02 – 10:09

Oral presentation · Abstract 76 · Brazil

Establishing GMP-Compliant CAR-T Cell Manufacturing at INCA: Infrastructure Adaptation and Manufacturing Readiness for an Upcoming Pediatric Clinical Trial in Brazil

10:30 – 11:00

Coffee break

11:00 – 12:15
Room 1

Non-Viral Delivery

Chair: Roberta Sessa Stilhano Yamaguchi

Sta. Casa SP · Brazil

Leonardo Martin11:00 – 11:20

University of Antwerp · Belgium

Delivering Regeneration: Non-Viral Gene Transfer Across Immunomodulatory and Regenerative Strategies

Ana Paula Dinis Ano Bom11:20 – 11:40

Biomanguinhos · Brazil

Nanoparticles for Advanced Therapy Delivery: Towards In Vivo CAR-T Cell Generation

Flávia Alves França11:40 – 11:47

Oral presentation · Abstract 170 · Brazil

Optimization and Preclinical Validation of an mRNA-LNP Vaccine Candidate Against Chikungunya Virus

Arthur da Silva Neumann11:47 – 11:54

Oral presentation · Abstract 57 · Brazil

Scaling up the non-viral production of CD19 CAR-T cells using a minicircle-based Sleeping Beauty transposon system.

Room 2

Regulatory and Innovation Advances in Brazil

Chair: Antônio Carlos Campos de Carvalho

UFRJ · Brazil

Lara Pereira11:00 – 11:20

ANVISA · Brazil

Advancing ATMP Regulation in Brazil: Innovation, Challenges and Opportunities

Luciana Pereira Almeida de Piano11:20 – 11:40

ARO-EINSTEIN · Brazil

Clinical Research Regulatory Landscape: Recent Updates

Elevation pitch by iOz Biotec startup12:00 – 12:15
12:00 – 13:30

Industry workshops

45 min presentation

Room 1

Terumo

Automated Cell Expansion System: From Research to Cell Therapy Manufacturing

Gloria Alejandra Bernal Ramos (Mexico)

Room 2

Instituto Butantan

NUTERA-RP and NUTERA-SP: A Project for Technological Sovereignty in the Production of and Access to Advanced Therapies in Brazil

Vanderson Rocha (Brazil) / Diego Clé (Brazil)

13:45 – 15:00
Room 1

Advanced Therapies for Cancer: Oncolytic Adenovirus and Nanoparticles

INTERGEN

Chair: Bryan Eric Strauss

ICESP · Brazil

Candelaria Gomez-Manzano13:45 – 14:10

MD Anderson Cancer Center · United States

The Emerging Field of Viroimmunotherapy for Pediatric Brain Tumors

Juan Fueyo14:10 – 14:35

MD Anderson Cancer Center · United States

From Glioma Cartography to Clinic: Mapping the Tumor Ecosystem to Predict Survival after Oncolytic Virus Therapy

Wagner José Fávaro14:35 – 15:00

UNICAMP · Brazil

Nanotechnological Platforms in Immuno-Oncology: Innovation and Therapeutic Impact

Room 2

From Science to Access: How Regulation, Innovation and Business Are Shaping Advanced Therapies

CCTA-EMBRAPII

Chair: Raquel de Melo Alves Paiva

Einstein Hospital Israelita · Brazil

Lucila Kerbauy13:45 – 14:05

Einstein Hospital Israelita · Brazil

The Brazilian Experience in Academic CAR-T Cell Manufacturing: Operational, Regulatory, and Clinical Challenges

Augusto Barbosa Jr14:05 – 14:25

Einstein Hospital Israelita · Brazil

Innovation Ecosystems in Advanced Therapies: Partnerships, Local Manufacturing, and Competitiveness

Eduardo Ferreira de Carvalho Netto14:25 – 14:45

Einstein Hospital Israelita · Brazil

The New Innovation Triad: Industry, Academia, and Patients

15:00 – 16:15
Room 1

Novel CAR-Based Therapies

Chair: Kelen Malmegrim de Farias

FCFRP-USP · Brazil

Thiago Aparecido da Silva15:00 – 15:20

UNESP · Araraquara · Brazil

CAR application for the treatment of invasive fungal infections

Rodrigo Nalio Ramos15:20 – 15:40

Instituto D'Or · Brazil

Generation of human CD34+ derived-macrophages expressing CARs for solid tumors control.

Lays Adrianne Mendonça Trajano Silva15:40 – 15:47

Oral presentation · Abstract 14 · Brazil

A Lentiviral EDV Platform for simultaneous CAR Engineering and CRISPR Gene Editing in Primary T and NK Cells

Julia Garcia Guimaraes15:47 – 15:54

Oral presentation · Abstract 79 · Brazil

Cell therapy targeting fungal pathogens: optimization of Mannan-Specific Chimeric Antigen Receptor (M-CAR)

Room 2

RNA-Based Strategies

Chair: Leonardo Martin

University of Antwerp · Belgium

Ricardo Titze15:00 – 15:20

UnB · Brazil

RNA-Based Therapeutics for Genetic Neurological Diseases: Promises, Challenges, and Future Directions

Tatiana Martins Tilli15:20 – 15:40

Fiocruz · Brazil

Network-Guided RNA Therapeutics: Using siRNA to Validate Novel Targets for Precision Oncology

Adne Vitória Rocha de Lima15:40 – 15:47

Oral presentation · Abstract 42 · Brazil

Isoform-resolved lncRNA remodeling as a secondary readout of SCN2A dosage and CRISPRa-mediated activation in human iPSC-derived cortical excitatory neurons

Jean Carlos dos Santos da Luz15:47 – 15:54

Oral presentation · Abstract 34 · Brazil

From cells to patients: gene therapy with p14ARF and interferon-β reveals antitumor and immunomodulatory mechanisms in canine neoplasms

16:15 – 16:45

Coffee break

16:45 – 17:45
Room 1

Mesenchymal Stem Cells

Chair: Tatiana Maron Gutierrez

Fiocruz · Brazil

Daniel Weiss16:45 – 17:07

University of Vermont · United States

MSCs: Why Aren't they Working in Clinical Trials

Patricia Rocco17:07 – 17:29

UFRJ · Brazil

Beyond Stem Cells: Extracellular Vesicles as a Novel Therapeutic Strategy for ARDS

17:45 – 18:45
Room 1

Frontiers in Molecular Medicine

Chair: Bruno Solano de Freitas Souza

Instituto D'Or · Brazil

Ross Wilson17:45 – 18:07

Innovative Genomics Institute · United States

Peptide-enabled ribonucleoprotein delivery for CRISPR engineering (PERC) in primary human immune cells and hematopoietic stem cells

Stevens Rehen18:07 – 18:29

Instituto D'Or · Brazil

Human Brain Organoids at the Crossroads of Viruses, Psychedelics, and Artificial Intelligence

18:45 – 20:15

Poster Session II

DAY 03

Thursday, November 5, 2026

08:30 – 16:30
08:30 – 09:15

Industry workshops

45 min presentation

Room 1

Illumina

Illumina Solutions for Sequencing and Multiomics Analysis Applied to Advanced Therapies

Rafael Carvalho (Brazil)

Room 2

CytoGenics and Miltenyi Biotec

Clinical-scale manufacturing of CD137+ enriched tumor-reactive T cells for glioblastoma in the CliniMACS Prodigy

Ian Hardy (Germany)

09:15 – 10:30
Room 1

Extracellular Vesicles

Chair: Ana Helena Paz

UFRGS · Brazil

Fernanda Ferreira Cruz09:15 – 09:35

UFRJ · Brazil

Extracellular vesicles derived from MSCs for Lung Diseases - Preclinical Evidences

Bruno Solano de Freitas Souza09:35 – 09:55

Instituto D'Or · Brazil

When the Secretome Becomes the Product: Translating MSC-Derived Extracellular Vesicles into an ARDS Clinical Trial

Tayná Rody09:55 – 10:02

Oral presentation · Abstract 59 · Brazil

Investigation of the neuroprotective role of extracellular vesicles from physical exercise and associated with FNDC5/irisin in preclinical models of Alzheimer's disease

Waldir César Ferreira de Oliveira10:02 – 10:09

Oral presentation · Abstract 104 · Brazil

3D Bioprinted Wound Dressings Containing 5-Azacytidine-Preconditioned Human Umbilical Cord Mesenchymal Stromal Cells for the Treatment of Severe Cutaneous Wounds in a Murine Model of Sickle Cell Disease

Room 2

In Vivo Gene Therapy

Chair: Ricardo Weinlich

Einstein Hospital Israelita · Brazil

Hilda Petrs Silva09:15 – 09:35

UFRJ · Brazil

Agnostic Gene Therapy

Guilherme Baldo09:35 – 09:55

UFRGS · Brazil

Gene therapy for inborn errors of metabolism

Lucas Bravo Perina09:55 – 10:02

Oral presentation · Abstract 17 · Brazil

Construction and evaluation of an HSV-1-based oncolytic virus expressing the pro-apoptotic protein sfTRAIL, for the treatment of head and neck tumors.

Anna Jéssia Duarte Silva10:02 – 10:09

Oral presentation · Abstract 146 · Brazil

Therapeutic DNA Vaccination Targeting HPV16 E5 and E7 Oncoproteins: Evaluation of Different Immunization Regimens in a Preclinical Tumor Model

10:30 – 11:00

Coffee break

11:00 – 12:00
Room 1

Past, Present and Future of AAVs

Chair: Hilda Petrs Silva

UFRJ · Brazil

Arun Srivastava11:00 – 11:22

University of Florida · United States

Need for the development of capsid- and genome-modified next generation of AAV vectors

Emilia Araujo Zin11:30 – 11:52

France

From Capsid Development to the Clinic

12:00 – 13:30

Industry workshops

45 min presentation

Room 1

ScaleReady

G-Rex®: The Past, Present, and Future of ex vivo CGT

Tony Pnewski (United States)

Room 2

ThermoFisher

Streamlining Cell Therapy Development and Manufacturing with Closed, Modular & Automated Solutions

Jenifer Nowatzki (Brazil)

13:30 – 14:45
Room 1

Cell Therapy for Cancer

Chair: Samuel Couto

Instituto Butantan · Brazil

Stephan Kadauke13:30 – 13:50

CHOP · United States

Transferring Point-of-Care CAR-T Manufacturing Between Institutions: What Travels and What Has to Be Rebuilt

Juliana Dias13:50 – 14:10

University College London · United Kingdom

From Concept to Clinic: Challenges in the Translation of Next-Generation CAR T Cell Therapies

Thaíssa Vitória Portal Rodrigues14:10 – 14:17

Oral presentation · Abstract 142 · Brazil

Phage display selection of scFvs specific for the HER2 S310F mutation from rationally designed libraries based on pertuzumab

Eloah Rabello Suarez14:17 – 14:24

Oral presentation · Abstract 6 · Brazil

Engineering CAR-T Cells to Enhance Tumor Infiltration in Solid Tumors

Room 2

Clinical Applications of Gene Therapy in Brazil

Chair: Guilherme Baldo

UFRGS · Brazil

Juliana Maria Ferraz Sallum13:30 – 13:50

Escola Paulista de Medicina · Brazil

Advanced Therapies in Ophthalmology

Jonas Alex Morales Saute13:50 – 14:10

UFRGS · Brazil

Gene Therapies in Practice: From Clinical Care to Early-Phase Clinical Trials

Maria Mascarenhas14:10 – 14:17

Oral presentation · Abstract 187 · Brazil

Will It Reach Patients? An AI Model Predicts Clinical Translation of Gene Therapies from Modifiable Preclinical Design Choices

Anita Campos Mendonça Silva14:17 – 14:24

Oral presentation · Abstract 198 · Brazil

Safety and Preliminary Efficacy of a Brazil-Developed CMV pp65-Specific T-Cell Therapy for Clinically Significant CMV Infection After Allogeneic Hematopoietic Stem Cell Transplantation: Interim Results of a Phase I Study

14:45 – 16:00
Room 1

Gene Therapy for Oncology

ONCOTTGEN

Chair: André Salim Khayat

Brazil

André Silva Pimentel14:45 – 15:05

PUC-RJ · Brazil

Rational Design of Inhibitors and Silencers of Cancer-Associated Genes Using Artificial Intelligence

Alfeu Zanotto-Filho15:05 – 15:25

UFSC · Brazil

What are the primary obstacles to achieving tissue- or tumor-selective gene therapy?

Pedro Guimaraes15:25 – 15:45

UFMG · Brazil

Nanoparticle-based cancer immunotherapy for nucleic acid delivery

Room 2

3D Modelling for Complex Diseases

INCT-Model3D

Chair: Vanessa Morais Freitas

USP · Brazil

Vanessa Morais Freitas14:45 – 15:05

USP · Brazil

Flow-Driven Regulation of Endothelial Morphology and Tumor Extracellular Vesicle Dynamics

Laura Nicoleti Zamproni15:05 – 15:25

Brazil

Organ-on-a-Chip Platforms: New Frontiers in CNS Disease Modeling

Fabio Papes15:25 – 15:45

UNICAMP · Brazil

Use of 3D cellular models to study the dysregulation of chemotactic signaling and neuronal migration in autism

16:00 – 16:30

Closing Session - Award Announcements

Room 1

GOLD SPONSOR

  • Bio-Manguinhos
  • Insttituto Butantan
  • Merck
  • Scale Ready
  • Terumo Blood and Cell Technologies
  • Vector Builder

SILVER SPONSOR

  • CytoGenics
  • Maxcyte
  • Thermofisher

BRONZE SPONSOR

  • Corning
  • GenScript
  • Interprise
  • Promega
  • Sinapse
  • Synthego

EXHIBITOR

  • Analitica

STARTUP

  • Biotech Solutions

SPONSOR SYMPOSIUM

  • Beckman
  • Illumina

SUPPORT

  • FAPERJ
  • Satorius
  • Eppendorf
  • Bayer
  • Caring Cross
  • BS Diagnóstica
  • Hemocentro Ribeirão Preto
  • Intrials
  • DBR
  • Lab Research